Sanofi Sued by Texas Attorney General Over Alleged Provider 'Bribery'

MT Newswires Live
02/20

Sanofi (SNY) has been sued by Texas Attorney General Ken Paxton over allegations that it offers improper incentives to healthcare providers to prescribe its drugs.

The Texas Attorney General's Office said Sanofi created programs that offered services to healthcare providers which amounted to bribes under the Texas Health Care Program Fraud Prevention Act.

Paxton is seeking more than $1 million in monetary relief, including civil penalties, as well as an injunction to halt any alleged unlawful conduct, the Attorney General's Office added.

Sanofi said the complaint mischaracterizes legitimate patient support programs, including nurse education and reimbursement assistance services.

The company added that the programs comply with federal and state laws.

"The state's intervention has no bearing on the merits of this case, and Sanofi is zealously defending this litigation," the drugmaker said in an emailed statement.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10